IL308035A - Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists - Google Patents

Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists

Info

Publication number
IL308035A
IL308035A IL308035A IL30803523A IL308035A IL 308035 A IL308035 A IL 308035A IL 308035 A IL308035 A IL 308035A IL 30803523 A IL30803523 A IL 30803523A IL 308035 A IL308035 A IL 308035A
Authority
IL
Israel
Prior art keywords
pyrenyl
triazole
tetrahydro
pyridine
acetic acid
Prior art date
Application number
IL308035A
Other languages
English (en)
Hebrew (he)
Inventor
Hongjian Zhang
Ping Chen
Zhenwei Cai
Fei Jiang
Peihua Sun
Original Assignee
Viva Star Biosciences Suzhou Co Ltd
Hongjian Zhang
Ping Chen
Zhenwei Cai
Fei Jiang
Peihua Sun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viva Star Biosciences Suzhou Co Ltd, Hongjian Zhang, Ping Chen, Zhenwei Cai, Fei Jiang, Peihua Sun filed Critical Viva Star Biosciences Suzhou Co Ltd
Publication of IL308035A publication Critical patent/IL308035A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL308035A 2021-04-30 2022-04-28 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists IL308035A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2021091510 2021-04-30
PCT/US2022/026832 WO2022232459A1 (en) 2021-04-30 2022-04-28 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists

Publications (1)

Publication Number Publication Date
IL308035A true IL308035A (en) 2023-12-01

Family

ID=81748636

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308035A IL308035A (en) 2021-04-30 2022-04-28 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists

Country Status (10)

Country Link
US (1) US20250230140A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330249A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024517769A (cg-RX-API-DMAC7.html)
KR (1) KR20240044386A (cg-RX-API-DMAC7.html)
CN (1) CN117751106A (cg-RX-API-DMAC7.html)
AU (1) AU2022264579A1 (cg-RX-API-DMAC7.html)
CA (1) CA3218258A1 (cg-RX-API-DMAC7.html)
IL (1) IL308035A (cg-RX-API-DMAC7.html)
MX (1) MX2023012830A (cg-RX-API-DMAC7.html)
WO (1) WO2022232459A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023109878A1 (zh) * 2021-12-15 2023-06-22 武汉人福创新药物研发中心有限公司 三氮唑类lpar1拮抗剂及其用途
CN121773091A (zh) * 2023-09-08 2026-03-31 西藏海思科制药有限公司 杂芳环衍生物的lpar1拮抗剂及其用途
IL326963A (en) * 2023-09-08 2026-05-01 Haisco Pharmaceutical Group Co Ltd LPAR1 antagonist and its use
WO2026119206A1 (zh) * 2024-12-05 2026-06-11 海思科医药集团股份有限公司 Lpar1拮抗剂药物组合物及其在医药上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7369125B2 (ja) * 2017-12-19 2023-10-25 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのイソキサゾールo-架橋カルバモイルシクロヘキシル酸
CA3085561A1 (en) * 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Cyclohexyl acid triazole azines as lpa antagonists
ES2946657T3 (es) * 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
CN111434655A (zh) * 2019-01-15 2020-07-21 武汉朗来科技发展有限公司 溶血磷脂酸受体拮抗剂及其制备方法
KR20220024548A (ko) * 2019-06-18 2022-03-03 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 트리아졸 카르복실산
IL300525A (en) * 2020-08-11 2023-04-01 Viva Star Biosciences Ltd Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists

Also Published As

Publication number Publication date
MX2023012830A (es) 2024-01-19
WO2022232459A1 (en) 2022-11-03
US20250230140A1 (en) 2025-07-17
EP4330249A1 (en) 2024-03-06
CN117751106A (zh) 2024-03-22
AU2022264579A1 (en) 2023-12-14
CA3218258A1 (en) 2022-11-03
JP2024517769A (ja) 2024-04-23
KR20240044386A (ko) 2024-04-04

Similar Documents

Publication Publication Date Title
EP4582426A4 (en) PAN-KRAS INHIBITOR COMPOUND
EP4610263A4 (en) PAN-KRAS INHIBITOR COMPOUND
EP4138818C0 (en) Injectable formulation
IL288174A (en) Pyrrolidine compounds
EP4351568A4 (en) HALLUCINOGEN-FATTY ACID COMBINATION
EP4227390A4 (en) COMPOSITION CONTAINING A REFRIGERANT FLUID
EP4148096A4 (en) COMPOSITION
EP4094582A4 (en) COMPOSITION
EP4061813C0 (en) PYRROLIDINE DERIVATIVES
DK4055021T3 (da) Heterocykliske rip1-inhiberende forbindelser
DK4259617T3 (da) Substituerede pyrazolpiperidincarboxylsyrer
EP4161580A4 (en) BIOCONJUGATES OF CANNABINOID HYALURONIC ACID
EP4279545A4 (en) COMPOSITION
EP4304549A4 (en) Antibiofilm preservative compositions
EP4213818C0 (en) OPTIMIZED INJECTABLE VETERINARY FORMULATION
EP4291042C0 (en) COMPOSITION DERIVED FROM OATS
EP4744631A1 (en) Cannula
EP4656252A4 (en) COMPOSITION
EP4553110A4 (en) COMPOSITION
JP1762087S (ja) フィールドスコープ
EP4509561A4 (en) COMPOSITION
EP4473837A4 (en) COMPOSITION
EP4460553C0 (en) ANTIFUNGAL COMPOSITION
EP4132523A4 (en) Novel n-aryl oxamic acids
EP4223850A4 (en) COMPOSITION